Literature DB >> 8981829

[Chemical constituents of original plants of Cimicifugae rhizoma in Chinese medicine].

N Sakurai1, M Nagai.   

Abstract

Cimicifugae Rhizoma have been used as an anti-inflammatory, analgesic and antipyretic remedy in the traditional Chinese medicines. Many 9,19-cyclolanostane glycosides have been isolated from Cimicifuga and related genera. Two biogenetically key compounds, acetylshengmanol xyloside and cimicifugoside H-1, were isolated and their chemical structures were elucidated by our group. The former compound seems to be the parent component of the other glycosides such as cimigenol xyloside from C. dahurica, C. iaponica and C. acerina. The latter glycoside, cimicifugoside H-1 was isolated together with cimicifugosides H-2-H-6 from commercial Cimicifugae Rhizoma. They are novel glycosides having a hydroxyl group ay C-11, and cimicifugosides H-3, H-4 and H-6 were trinor-triterpenol glycosides. Cimicifugoside H-1 changed into H-2, H-3 and H-4 under acidic or alkaline conditions. In this review, the structure elucidation of the above glycosides and their chemical transformation into other Cimicifuga glycosides are described.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8981829     DOI: 10.1248/yakushi1947.116.11_850

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  2 in total

1.  Evaluation of the effects of Cimicifugae Rhizoma on the morphology and viability of mesenchymal stem cells.

Authors:  Su-Hyeon Jeong; Ji-Eun Lee; Bo-Bae Kim; Youngkyung Ko; Jun-Beom Park
Journal:  Exp Ther Med       Date:  2015-06-15       Impact factor: 2.447

2.  Cimicifuga species identification by high performance liquid chromatography-photodiode array/mass spectrometric/evaporative light scattering detection for quality control of black cohosh products.

Authors:  Kan He; Guido F Pauli; Bolin Zheng; Huikang Wang; Naisheng Bai; Tangsheng Peng; Marc Roller; Qunyi Zheng
Journal:  J Chromatogr A       Date:  2006-03-02       Impact factor: 4.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.